Cargando…
A Review of the Pharmacokinetic Characteristics of Immune Checkpoint Inhibitors and Their Clinical Impact Factors
Immune checkpoint inhibitors (ICIs) have been shown to be significant in improving the overall survival rate in certain malignancies with poor prognoses. However, only 20–40% of patients achieve long-term benefits, highlighting the relevance of the factors that influence the treatment, which can hel...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9880024/ https://www.ncbi.nlm.nih.gov/pubmed/36714524 http://dx.doi.org/10.2147/PGPM.S391756 |